Sangel Capital

Sangel Capital is a biomedical venture capital firm founded in 2010 and based in Shenzhen, China, focused on investments in the life sciences and biomedicine sectors. The firm provides capital to companies developing innovative healthcare, biopharmaceutical, and medical technology solutions, with a particular emphasis on opportunities in the Chinese life sciences market. The firm operates as a healthcare-focused institutional investor targeting early and growth-stage biomedical companies in China and the broader Asia-Pacific life sciences ecosystem.